Cathepsin L Plays a Role in Quinolinic Acid-Induced NF-Κb Activation and Excitotoxicity in Rat Striatal Neurons

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Wang, Yan Ru ^a   Qin, Shu ^a   Han, Rong ^a   Wu, Jun Chao ^a   Liang, Zhong Qin ^a   Qin, Zheng Hong ^a   Wang, Yan ^a  

^a MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

1 NAPHTHALENESULFONYL IW CHO; BECLIN 1; CASPASE 3; CATHEPSIN L; CYSTEINE PROTEINASE INHIBITOR; I KAPPA B KINASE; I KAPPA B KINASE ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LENTINAN; PHOSPHO I KAPPA B KINASE ALPHA; PROTEIN P53; PROTEIN P62; QUINOLINIC ACID; UNCLASSIFIED DRUG; Z FF FMK;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CELL NUCLEUS; CELL TRANSFER; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; EXCITOTOXICITY; IMMUNOHISTOCHEMISTRY; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; STEREOTAXIS; STRIATE CORTEX; UPREGULATION; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CATHEPSIN L; CELL PROLIFERATION; CELLS, CULTURED; CORPUS STRIATUM; CYSTEINE PROTEINASE INHIBITORS; DIPEPTIDES; FLUORESCENT ANTIBODY TECHNIQUE; GLUTAMIC ACID; KETONES; MALE; NEURONS; NF-KAPPA B; PROTEOLYSIS; QUINOLINIC ACID; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84884471192     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0075702     Document Type: Article

References (66)

1. Cull-Candy S, Brickley S, Farrant M, (2001) NMDA receptor subunits: diversity, development and disease. Curr Opin Neurobiol 11: 327-335.
2. Waxman EA, Lynch DR, (2005) N-methyl-D-aspartate receptor subtypes: multiple roles in excitotoxicity and neurological disease. Neuroscientist 11: 37-49.
3. Yamakura T, Shimoji K, (1999) Subunit- and site-specific pharmacology of the NMDA receptor channel. Prog Neurobiol 59: 279-298.
4. Shen H, Kihara T, Hongo H, Wu X, Kem WR, et al. (2010) Neuroprotection by donepezil against glutamate excitotoxicity involves stimulation of alpha7 nicotinic receptors and internalization of NMDA receptors. Br J Pharmacol 161: 127-139.
5. Haik KL, Shear DA, Schroeder U, Sabel BA, Dunbar GL, (2000) Quinolinic acid released from polymeric brain implants causes behavioral and neuroanatomical alterations in a rodent model of Huntington's disease. Exp Neurol 163: 430-439.
6. Dong XX, Wang Y, Qin ZH, (2009) Molecular mechanisms of excitotoxicity and their relevance to pathogenesis of neurodegenerative diseases. Acta Pharmacol Sin 30: 379-387.
7. Wang Y, Qin ZH, (2010) Molecular and cellular mechanisms of excitotoxic neuronal death. Apoptosis 15: 1382-1402.
8. Nakai M, Qin ZH, Wang YM, Chase TN, (2000) NMDA and non-NMDA receptor-stimulated I kappa B-alpha degradation: differential effects of the caspase-3 inhibitor DEVD center dot CHO, ethanol and free radical scavenger OPC-14117. Brain Res 859: 207-216.
9. Wang Y, Dong XX, Cao Y, Liang ZQ, Han R, et al. (2009) p53 induction contributes to excitotoxic neuronal death in rat striatum through apoptotic and autophagic mechanisms. Eur J Neurosci 30: 2258-2270.
10. Mizushima N, Ohsumi Y, Yoshimori T, (2002) Autophagosome formation in mammalian cells. Cell Struct Funct 27: 421-429.
11. Yue ZY, Friedman L, Komatsu M, Tanaka K, (2009) The cellular pathways of neuronal autophagy and their implication in neurodegenerative diseases. Biochimica Et Biophysica Acta-Molecular Cell Research 1793: 1496-1507.
12. Wang Y, Han R, Liang ZQ, Wu JC, Zhang XD, et al. (2008) An autophagic mechanism is involved in apoptotic death of rat striatal neurons induced by the non-N-methyl-D-aspartate receptor agonist kainic acid. Autophagy 4: 214-226.
13. Wang Y, Gu ZL, Cao Y, Liang ZQ, Han R, et al. (2006) Lysosomal enzyme cathepsin B is involved in kainic acid-induced excitotoxicity in rat striatum. Brain Res 1071: 245-249.
14. Yokota S, Nishimura Y, Kato K, (1988) Localization of cathepsin L in rat kidney revealed by immunoenzyme and immunogold techniques. Histochemistry 90: 277-283.
15. Ryvnyak VV, Ryvnyak EI, Tudos RV, (2004) Electron histochemical localization of cathepsin L in the liver. Bull Exp Biol Med 137: 90-91.
16. Ishidoh K, Kominami E, (2002) Processing and activation of lysosomal proteinases. Biol Chem 383: 1827-1831.
17. Nakagawa T, Roth W, Wong P, Nelson A, Farr A, et al. (1998) Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus. Science 280: 450-453.
18. Chapman HA, Riese RJ, Shi GP, (1997) Emerging roles for cysteine proteases in human biology. Annu Rev Physiol 59: 63-88.
19. Goto T, Kiyoshima T, Moroi R, Tsukuba T, Nishimura Y, et al. (1994) Localization of cathepsins B, D, and L in the rat osteoclast by immuno-light and-electron microscopy. Histochemistry 101: 33-40.
20. Waguri S, Sato N, Watanabe T, Ishidoh K, Kominami E, et al. (1995) Cysteine proteinases in GH4C1 cells, a rat pituitary tumor cell line, are secreted by the constitutive and regulated secretory pathways. Eur J Cell Biol 67: 308-318.
21. Collette J, Bocock JP, Ahn K, Chapman RL, Godbold G, et al. (2004) Biosynthesis and alternate targeting of the lysosomal cysteine protease cathepsin L. Int Rev Cytol 241: 1-51.
22. Funkelstein L, Beinfeld M, Minokadeh A, Zadina J, Hook V, (2010) Unique biological function of cathepsin L in secretory vesicles for biosynthesis of neuropeptides. Neuropeptides 44: 457-466.
23. Felbor U, Kessler B, Mothes W, Goebel HH, Ploegh HL, et al. (2002) Neuronal loss and brain atrophy in mice lacking cathepsins B and L. Proc Natl Acad Sci U S A 99: 7883-7888.
24. Lankelma JM, Voorend DM, Barwari T, Koetsveld J, Van der Spek AH, et al. (2010) Cathepsin L, target in cancer treatment? Life Sci 86: 225-233.
25. Sevenich L, Pennacchio LA, Peters C, Reinheckel T, (2006) Human cathepsin L rescues the neurodegeneration and lethality in cathepsin B/L double-deficient mice. Biol Chem 387: 885-891.
26. Gonzalez-Suarez I, Redwood AB, Grotsky DA, Neumann MA, Cheng EH, et al. (2011) A new pathway that regulates 53BP1 stability implicates cathepsin L and vitamin D in DNA repair. EMBO J 30: 3383-3396.
27. Ditaranto K, Tekirian TL, Yang AJ, (2001) Lysosomal membrane damage in soluble Abeta-mediated cell death in Alzheimer's disease. Neurobiol Dis 8: 19-31.
28. Fei XF, Qin ZH, Xiang B, Li LY, Han F, et al. (2009) Olomoucine inhibits cathepsin L nuclear translocation, activates autophagy and attenuates toxicity of 6-hydroxydopamine. Brain Res 1264: 85-97.
29. Xiang B, Fei X, Zhuang W, Fang Y, Qin Z, et al. (2011) Cathepsin L is involved in 6-hydroxydopamine induced apoptosis of SH-SY5Y neuroblastoma cells. Brain Res 1387: 29-38.
30. Nakai M, Qin ZH, Wang Y, Chase TN, (1999) Free radical scavenger OPC-14117 attenuates quinolinic acid-induced NF-kappaB activation and apoptosis in rat striatum. Brain Res Mol Brain Res 64: 59-68.
31. Tardy C, Codogno P, Autefage H, Levade T, Andrieu-Abadie N, (2006) Lysosomes and lysosomal proteins in cancer cell death (new players of an old struggle). Biochim Biophys Acta 1765: 101-125.
32. Nakai M, Qin ZH, Chen JF, Wang YM, Chase TN, (2000) Kainic acid-induced apoptosis in rat striatum is associated with nuclear factor-kappa B activation. J Neurochem 74: 647-658.
33. Qin ZH, Chen RW, Wang Y, Nakai M, Chuang DM, et al. (1999) Nuclear factor kappaB nuclear translocation upregulates c-Myc and p53 expression during NMDA receptor-mediated apoptosis in rat striatum. J Neurosci 19: 4023-4033.
34. Qin ZH, Wang Y, Chase TN, (1996) Stimulation of N-methyl-D-aspartate receptors induces apoptosis in rat brain. Brain Res 725: 166-176.
35. Aleyasin H, Cregan SP, Iyirhiaro G, O'Hare MJ, Callaghan SM, et al. (2004) Nuclear factor-kappa B modulates the p53 response in neurons exposed to DNA damage. J Neurosci 24: 2963-2973.
36. Levine AJ, (1997) p53, the cellular gatekeeper for growth and division. Cell 88: 323-331.
37. Dai C, Tang Y, Jung SY, Qin J, Aaronson SA, et al. (2011) Differential effects on p53-mediated cell cycle arrest vs. apoptosis by p90. Proc Natl Acad Sci U S A 108: 18937-18942.
38. Henkels KM, Turchi JJ, (1999) Cisplatin-induced apoptosis proceeds by caspase-3-dependent and-independent pathways in cisplatin-resistant and-sensitive human ovarian cancer cell lines. Cancer Res 59: 3077-3083.
39. Yang Z, Klionsky DJ, (2010) Mammalian autophagy: core molecular machinery and signaling regulation. Curr Opin Cell Biol 22: 124-131.
40. Kabeya Y, Mizushima N, Uero T, Yamamoto A, Kirisako T, et al. (2000) LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J 19: 5720-5728.
41. Boland B, Campbell V, (2004) Abeta-mediated activation of the apoptotic cascade in cultured cortical neurones: a role for cathepsin-L. Neurobiol Aging 25: 83-91.
42. Grilli M, Pizzi M, Memo M, Spano P, (1996) Neuroprotection by aspirin and sodium salicylate through blockade of NF-kappa B activation. Science 274: 1383-1385.
43. Qin ZH, Wang YM, Nakai M, Chase TN, (1998) Nuclear factor-kappa B contributes to excitotoxin-induced apoptosis in rat striatum. Mol Pharmacol 53: 33-42.
44. Ghosh S, May MJ, Kopp EB, (1998) NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 16: 225-260.
45. O'Neill LA, Kaltschmidt C, (1997) NF-kappa B: a crucial transcription factor for glial and neuronal cell function. Trends Neurosci 20: 252-258.
46. Baeuerle PA, Baltimore D, (1996) NF-kappa B: ten years after. Cell 87: 13-20.
47. Lahiry L, Saha B, Chakraborty J, Bhattacharyya S, Chattopadhyay S, et al. (2008) Contribution of p53-mediated Bax transactivation in theaflavin-induced mammary epithelial carcinoma cell apoptosis. Apoptosis 13: 771-781.
48. Chipuk JE, Kuwana T, Bouchier-Hayes L, Droin NM, Newmeyer DD, et al. (2004) Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science 303: 1010-1014.
49. Miyoshi N, Naniwa K, Kumagai T, Uchida K, Osawa T, et al. (2005) alpha-Tocopherol-mediated caspase-3 up-regulation enhances susceptibility to apoptotic stimuli. Biochem Biophys Res Commun 334: 466-473.
50. Dong XX, Wang YR, Qin S, Liang ZQ, Liu BH, et al. (2012) p53 Mediates autophagy activation and mitochondria dysfunction in kainic acid-induced excitotoxicity in primary striatal neurons. Neuroscience 207: 52-64.
51. Zhang XD, Wang Y, Zhang X, Han R, Wu JC, et al. (2009) p53 mediates mitochondria dysfunction-triggered autophagy activation and cell death in rat striatum. Autophagy 5: 339-350.
52. Wang N, Pan W, Zhu M, Zhang M, Hao X, et al. (2011) Fangchinoline induces autophagic cell death via p53/sestrin2/AMPK signalling in human hepatocellular carcinoma cells. Br J Pharmacol 164: 731-742.
53. Suzuki K, Ohsumi Y, (2007) Molecular machinery of autophagosome formation in yeast, Saccharomyces cerevisiae. FEBS Lett 581: 2156-2161.
54. Tanida I, Tanida-Miyake E, Komatsu M, Ueno T, Kominami E, (2002) Human Apg3p/Aut1p homologue is an authentic E2 enzyme for multiple substrates, GATE-16, GABARAP, and MAP-LC3, and facilitates the conjugation of hApg12p to hApg5p. J Biol Chem 277: 13739-13744.
55. Ichimura Y, Kirisako T, Takao T, Satomi Y, Shimonishi Y, et al. (2000) A ubiquitin-like system mediates protein lipidation. Nature 408: 488-492.
56. Shacka JJ, Klocke BJ, Shibata M, Uchiyama Y, Datta G, et al. (2006) Bafilomycin A1 inhibits chloroquine-induced death of cerebellar granule neurons. Mol Pharmacol 69: 1125-1136.
57. Komatsu M, Waguri S, Koike M, Sou Y, Ueno T, et al. (2007) Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice. Cell 131: 1149-1163.
58. Shvets E, Fass E, Scherz-Shouval R, Elazar Z, (2008) The N-terminus and Phe52 residue of LC3 recruit p62/SQSTM1 into autophagosomes. J Cell Sci 121: 2685-2695.
59. Pankiv S, Clausen TH, Lamark T, Brech A, Bruun JA, et al. (2007) p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J Biol Chem 282: 24131-24145.
60. Bjorkoy G, Lamark T, Brech A, Outzen H, Perander M, et al. (2005) p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death. J Cell Biol 171: 603-614.
61. Ichimura Y, Kumanomidou T, Sou YS, Mizushima T, Ezaki J, et al. (2008) Structural basis for sorting mechanism of p62 in selective autophagy. J Biol Chem 283: 22847-22857.
62. Noda NN, Kumeta H, Nakatogawa H, Satoo K, Adachi W, et al. (2008) Structural basis of target recognition by Atg8/LC3 during selective autophagy. Genes Cells 13: 1211-1218.
63. Boya P, Kroemer G, (2008) Lysosomal membrane permeabilization in cell death. Oncogene 27: 6434-6451.
64. Wang Y, Qin ZH, (2013) Coordination of autophagy with other cellular activities. Acta Pharmacol Sin. 34: 585-594.
65. Pan JA, Fan Y, Gandhirajan RK, Madesh M, Zong WX, (2013) Hyperactivation of the mammalian degenerin MDEG promotes caspase-8 activation and apoptosis. J Biol Chem 288: 2952-2963.
66. Liu C, Gao Y, Barrett J, Hu B, (2010) Autophagy and protein aggregation after brain ischemia. J Neurochem 115: 68-78.